Opaleye Management Inc. Karyopharm Therapeutics Inc. Transaction History

Opaleye Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.87 - $1.58 $1.24 Million - $2.25 Million	1,425,000 New	1,425,000 $1.24 Million
Q2 2023 Aug 14, 2023	SELL	$1.79 - $4.59 $1.84 Million - $4.71 Million	-1,025,800 Reduced 36.49%	1,785,000 $3.2 Million
Q1 2023 May 12, 2023	BUY	$2.84 - $3.92 $4.56 Million - $6.29 Million	1,603,959 Added 132.91%	2,810,800 $10.9 Million
Q4 2022 Feb 10, 2023	BUY	$2.48 - $5.93 $2.99 Million - $7.16 Million	1,206,841 New	1,206,841 $4.1 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.